In terms of CD147’s functions during tumor progression, the colorectal carcinoma progression is owing to the up-regulation of CD147 without the alteration of its glycosylation [61]; however, in other conditions, researchers observed the anomalous glycosylation or the combination of the two changes [57,62–64]. This evidence concerns the gene BSG and colorectal carcinoma.